NF-kB, a transcription factor, studied for an anticancer effect.

A study report attracts many interests, covering that NF-kB, a transcription factor, may physiologically eradicate cancer cells, which suggested a possibility of utilizing it for a new cancer drug. The report was presented by Prof. Kim Kyung-mee, Wonkwang Univ. college of pharmacy during the symposium of Korea Society of Pharmaceutics on April 27 under the title "The role of NF-kB in apoptosis ...